About
1.41USD-0.09 -6.00%
Closed • Updated at 13:22 GMT+00:00Market Cap$3.75M
Volume43.5K
Beta1.96
RSI39.23
Gross Margin39.60%
60 Degrees Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 26 2026
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis
May 15 2026
60 Degrees Pharmaceuticals Announces First Quarter 2026 Results
Apr 15 2026
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
Mar 31 2026
60 Degrees Pharmaceuticals Announces 2025 Annual Results
Mar 18 2026
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract
Recent Videos

60 Degrees Pharmaceuticals (SXTP) | Biotech Resurgence Conference Replay
Apr 20, 2026

RedChip Highlights Interview with Jay Hatfield & Sixty Degrees Pharma (NASDAQ: SXTP)
Apr 04, 2026

How to Buy Shares of 60 Degrees Pharmaceuticals Inc (SXTP)
Mar 28, 2026

60 DEGREES PHARMACEUTICALS | NASDAQ: SXTP Dr. Geoffrey Dow, founder and CEO of 60 Degrees Pharm...
Mar 25, 2026
Community Chat
Ask AI
Try asking
Translate